Acalabrutinib Impurity 13
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

1420478-90-5Acalabrutinib Impurity 13

● 재고 있음

카탈로그 번호:VE0023233
CAS 번호:1420478-90-5
분자식:C22H21N7O
분자량:399.45 g/mol

에 대한 추가 정보 CAS 1420478-90-5

모약물

Acalabrutinib

IUPAC명

(S)-4-(8-amino-3-(pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

약전 동의어

N/A

Other Synonyms

N/A

SMILES

O=C(C1=CC=C(C2=C(C(N)=NC=C3)N3C([C@H]4NCCC4)=N2)C=C1)NC5=CC=CC=N5

InChI

InChI=1S/C22H21N7O/c23-20-19-18(28-21(16-4-3-11-24-16)29(19)13-12-26-20)14-6-8-15(9-7-14)22(30)27-17-5-1-2-10-25-17/h1-2, 5-10, 12-13, 16, 24H, 3-4, 11H2, (H2, 23, 26)(H, 25, 27, 30)/t16-/m0/s1

설명

The Acalabrutinib Impurity 13 standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Acalabrutinib. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes. To further support research and development | it comes with a comprehensive Structure Elucidation Report (SER) | providing detailed insights for advanced analysis.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url